BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
PRODID:-//Drupal iCal API//EN
BEGIN:VEVENT
UID:calendar.3152.field_conference_start_date.0.0
SUMMARY:Thank you for attending the 15th Annual BIO CEO & Investor Conference
DTSTAMP::20140210T170000Z
DTSTART:20140210T170000Z
DTEND:20140211T170000Z
URL;VALUE=URI:http://www.bio.org/events/conferences/bio-ceo-investor-conference
DESCRIPTION:/Mark your calendars for next year: February 10th - 11th\, 2014/\n \n The BIO CEO & Investor Conference is the largest investor conference focused  \n on established and emerging publicly traded and select private biotech  \n companies. Because our mission is to support industry-wide success\, we  \n present a broad and unbiased view of investment opportunities.\n \n BIO One-on-One Partnering [1] provides an opportunity to arrange meetings  \n between investors\; companies\; and industry BD\, licensing and therapeutic  \n franchise heads.\n \n More about One-on-One Partnering events [2]\n \n ------------------------------------------------------------------------------\n /"The BIO CEO & Investor Conference has really grown in stature and  \n importance over the last several years." /\n \n -Adam Feuerstein\, Sr. Columnist for TheStreet [3]\n \n ------------------------------------------------------------------------------\n  \n \n Subscribe to the BIO Business Link [4]\, a biweekly newsletter featuring  \n in-depth industry analysis and critical thinking.\n \n  \n \n .... Biotech Industry News and Analysis\n \n  * Biobuck M&A in Full Gear [5]\n  * Mid-Priced Biotechnology Companies Bloom As M&A Targets in 2013 [6]\n  * A Big Year for Novel Drug Approvals [7]\n  * Drug Industry Bets on New Blockbusters in 2013 [8]\n  * Tufts: Billions Wasted in Pharma R&D Despite New Biz Models [9]\n \n  \n \n .... What can the BIO CEO & Investor Conference do for your company?\n \n \n \n \n \n \n [1] http://www.bio.org/node/3167/\n [2] http://www.bio.org/node/4954\n [3] http://www.thestreet.com/video/11835757/the-next-big-thing-in-biotech-bio-ceo-conference.html\n [4] http://www.bio.org/node/13856\n [5] http://www.biotech-now.org/business-and-investments/inside-bio-ia/2013/02/biobuck-ma-in-full-gear#\n [6] http://www.xconomy.com/san-francisco/2013/01/10/mid-priced-biotechnology-companies-bloom-as-ma-targets-in-2013/\n [7] http://www.biotech-now.org/business-and-investments/inside-bio-ia/2013/01/a-big-year-for-novel-drugs-approvals\n [8] http://www.reuters.com/article/2013/01/15/us-pharmaceuticals-idUSBRE90E0G620130115\n [9] http://www.fiercebiotech.com/story/tufts-billions-wasted-pharma-rd-despite-new-biz-models/2013-01-08
END:VEVENT
END:VCALENDAR